This topic contains a solution. Click here to go to the answer

Author Question: What role does surfactant play in preventing respiratory distress syndrome in premature infants? ... (Read 127 times)

itsmyluck

  • Hero Member
  • *****
  • Posts: 546
What role does surfactant play in preventing respiratory distress syndrome in premature infants?
 
  What will be an ideal response?

Question 2

Patients with obstructive sleep apnea who stop breathing many times a night can be treated with a CPAP apparatus to keep the airway open.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

frejo

  • Sr. Member
  • ****
  • Posts: 349
Answer to Question 1

Surfactant is present in the alveoli of the lungs to keep the air sacs open. Respiratory distress syndrome develops in premature infants who produce too little surfactant in their lungs.

Answer to Question 2

TRUE





 

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

The average older adult in the United States takes five prescription drugs per day. Half of these drugs contain a sedative. Alcohol should therefore be avoided by most senior citizens because of the dangerous interactions between alcohol and sedatives.

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

For a complete list of videos, visit our video library